ThermoDox heat-activated liposome regulatory update

FDA granted Orphan Drug designation for Celsion's ThermoDox heat-activated liposome to treat hepatocellular carcinoma (HCC). The doxorubicin encapsulated in a heat-activated liposome is in Phase III t...